World Journal of Diabetes - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4766)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

WORD

HTML

3054

Sum=3169

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

377

Download

501

Sum=878

Publishing Process of This Article

Item

Count

Browse

162

Download

343

Sum=505

Feb 15, 2024 (publication date) through Apr 6, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Nassar M, Chaudhuri A, Ghanim H, Dandona P. Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon. World J Diabetes 2024; 15(2): 133-136 [PMID: 38464377 DOI: 10.4239/wjd.v15.i2.133]
URL:	https://www.wjgnet.com/1948-9358/full/v15/i2/133.htm

Number	Citing Articles
1	Sujatha Seetharaman, Eda Cengiz. The Promise of Adjunct Medications in Improving Type 1 Diabetes Outcomes: Glucagon-Like Peptide Receptor Agonists. Journal of Diabetes Science and Technology 2025; 19(2): 311 doi: 10.1177/19322968241309896
2	Marco Infante, Francesca Silvestri, Nathalia Padilla, Francesca Pacifici, Donatella Pastore, Marcelo Maia Pinheiro, Massimiliano Caprio, Manfredi Tesauro, Andrea Fabbri, Giuseppe Novelli, Rodolfo Alejandro, Antonino De Lorenzo, Camillo Ricordi, David Della-Morte. Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults. Journal of Clinical Medicine 2025; 14(4): 1303 doi: 10.3390/jcm14041303
3	Hyder O Mirghani. Glucagon-like peptide-1 agonists: Role of the gut in hypoglycemia unawareness, and the rationale in type 1 diabetes. World Journal of Diabetes 2024; 15(11): 2167-2172 doi: 10.4239/wjd.v15.i11.2167 Abstract(292) \| Core Tip(279) \| Full Article(HTML)(992) \| Full Article with Cover (PDF)-810K(37) \| Audio-746K(1) \| Peer-Review Report-201K(32) \| Answering Reviewers-28K(30) \| Full Article (PDF)-378K(72) \| Full Article (XML)-84K(35) \| Times Cited (0) \| Total Visits (2414) \| Open
4	Mahmoud Nassar, Angad Singh Gill, Erlin Marte. Investigating the impact of intestinal glucagon-like peptide-1 on hypoglycemia in type 1 diabetes. World Journal of Diabetes 2025; 16(3): 99142 doi: 10.4239/wjd.v16.i3.99142 Abstract(175) \| Core Tip(162) \| Full Article(HTML)(512) \| Full Article with Cover (PDF)-1633K(22) \| Audio-725K(5) \| Peer-Review Report-220K(21) \| Answering Reviewers-75K(23) \| Supplementary Material-278K(22) \| Full Article (PDF)-1390K(43) \| Full Article (XML)-80K(22) \| Times Cited (0) \| Total Visits (1313) \| Open
5	Mahmoud Nassar, Omar Nassar, Hazem Abosheaishaa, Anoop Misra. Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2024; 18(9): 103116 doi: 10.1016/j.dsx.2024.103116